Dyspnoea – a valuable clue in a rare disease diagnosis

1 Pietra GG, Capron F, Stewart S, Leone O, Humbert M, Robbins IM, et al., Pathologic assessment of vasculopathies in pulmonary hypertension. Journal of the American College of Cardiology. 2004;43(12 Suppl): 25S–32S. doi:10.1016/j. jacc.2004.02.033. Search in Google Scholar

2 Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al. Updated clinical classification of pulmonary hypertension. Journal of the American College of Cardiology. 2013;62(25 Suppl): D34–D41. doi:10.1016/j.jacc.2013.10.029. Search in Google Scholar

3 Huertas A, Girerd B, Dorfmuller P, O’Callaghan D, Humbert M, Montani D. Pulmonary veno-occlusive disease: advances in clinical management and treatments. Expert Review of Respiratory Medicine. 2011;5(2): 217–231. doi:10.1586/ers.11.15. Search in Google Scholar

4 Montani D, Price LC, Dorfmuller P, Achouh L, Jaïs X, Yaïci A, et al. Pulmonary veno-occlusive disease. European Respiratory Journal. 2009;33: 189–200. doi:10.1183/09031936.00090608. Search in Google Scholar

5 Eyries M, Montani D, Girerd B, Perret C, Leroy A, Lonjou C, et al. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension. Nature Genetics. 2014;46: 65–69. doi:10.1038/ng.2844. Search in Google Scholar

6 Masters K, Bennett S. Pulmonary veno-occlusive disease: an uncommon cause of pulmonary hypertension. BMJ Case Reports. 2013;2013: bcr2012007752. doi:10.1136/bcr-2012-007752. Search in Google Scholar

7 Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal. 2022;43(38): 3618–3731. https://doi.org/10.1093/eurheartj/ehac237. Search in Google Scholar

8 Balko R, Edriss H, Nugent K, Test V. Pulmonary veno-occlusive disease: an important consideration in patients with pulmonary hypertension. Respiratory Medicine. 2017;132: 202–209. doi:10.1016/j.rmed.2017.10.015. Search in Google Scholar